These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 742076)

  • 1. [Demonstration of cellular immunity by means of the leukocyte adherence inhibition (LAI) test in female breast neoplasms].
    Fritze D; Ellinger K; Mayer D; Kaufmann M; Drings P; Döhnert G
    Verh Dtsch Ges Inn Med; 1978; (84):577-9. PubMed ID: 742076
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanisms, kinetics and specificity of the leukocyte adherence inhibition test in breast cancer].
    Kharkevich DD; Polevaia EB; Derevnina NA; Sablikova IuA; Savinov AIu
    Eksp Onkol; 1985; 7(6):69-73. PubMed ID: 3910405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunodiagnostic aspects of breast cancer. The phenomenon of leukocyte adherence inhibition].
    Fritze D; Fritze J; Kaufmann M; Drings P
    Minerva Med; 1978 Nov; 69(58):3963-7. PubMed ID: 740287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Micromodification of the leukocyte adherence inhibition test for cancer patients].
    Kharkevich DD; Tabagari DZ; Savinov AIu
    Vopr Onkol; 1985; 31(7):17-21. PubMed ID: 3895734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated immunity and serum blocking by radioisotopic leukocyte adherence inhibition assay.
    Tsang PH; Holland JF; Bekesi JG
    Mt Sinai J Med; 1985 Mar; 52(3):193-200. PubMed ID: 3887140
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunologic studies using the leukocyte adherence inhibition test in the diagnosis and postoperative follow-up of breast cancer].
    Storch H; Granetzny A
    Z Gesamte Inn Med; 1987 Jan; 42(2):41-4. PubMed ID: 3554795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral leukocyte adherence inhibition (H-LAI) before and after surgery in human breast cancer.
    Horváth M; Tóth L; Tóth J; Fekete B
    Neoplasma; 1985; 32(5):623-7. PubMed ID: 3906415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparison of methods for determination of humoral and cell-mediated immunity in patients with breast cancer.
    Nedbalová M; Trojan S; Dohnalová A; Jandová A
    Electromagn Biol Med; 2009; 28(3):233-9. PubMed ID: 20001700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique.
    Kotlar HK; Sanner T
    J Natl Cancer Inst; 1981 Feb; 66(2):265-71. PubMed ID: 7005505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
    Tsang PH; Holland JF; Bekesi JG
    J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte adherence inhibition responses obtained with various tumor extracts in breast cancer patients.
    Kovarík J; Lauerová L; Feit J; Ninger E; Munzarová M; Zemanová D; Hlávková J
    Cancer Detect Prev; 1983; 6(1-2):215-9. PubMed ID: 6349799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte adherence inhibition (LAI) test, LAI. Trypsin and LAI. Humoral test in large term immunotherapy with levamisole on breast and colon cancer.
    De Carli HO; Restbergs V
    Rev Esp Oncol; 1983; 30(1):25-39. PubMed ID: 6387830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of leukocyte adherence inhibition test to study the cell mediated antitumour immunity in cancer patients.
    Shirodkar SR; Gangal SG
    Indian J Med Res; 1979 Jul; 70():88-96. PubMed ID: 387584
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of surgery on antitumor immunity measured by tube leukocyte adherence inhibition assay in breast cancer.
    Flores M; Thomson DM; MacFarlane JK
    Surg Forum; 1976; 27(62):91-3. PubMed ID: 1020006
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of antitumor immunity against cancer of the breast by leukocyte adherence inhibition in test tubes.
    Marti JR; Thomson DM; MacFarlane JK
    Surg Forum; 1975; 26():168-70. PubMed ID: 1216101
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunological mechanisms of tube leukocyte adherence inhibition.
    Thomson DM; Grosser N
    Cancer Res; 1979 Feb; 39(2 Pt 2):576-81. PubMed ID: 83912
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
    Ludwig HJ; Storch H
    Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes.
    Grosser N; Thomson DM
    Cancer Res; 1975 Sep; 35(9):2571-9. PubMed ID: 1097110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor immunity in breast cancer evaluated by a computerized tube leukocyte adherence inhibition (LAI) assay.
    Fink A; Shani A; Feldman B; Wechsler U; Pfeffermann R; Eliraz A; Offer S; Harpaz N; Bentwich Z
    Eur J Surg Oncol; 1989 Feb; 15(1):17-9. PubMed ID: 2645173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirement for autologous cancer extracts and lipoxygenation of arachidonic acid for human T-cell responses in leukocyte adherence inhibition and transmembrane potential change assays.
    Shenouda G; Thomson DM; MacFarlane JK
    Cancer Res; 1984 Mar; 44(3):1238-45. PubMed ID: 6420056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.